申请人:COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
公开号:US11168084B2
公开(公告)日:2021-11-09
The present invention provides novel purine based compounds of formula 1, method of preparation of purine based compounds and its composition useful for inhibiting signalling through Toll-like receptors. These compounds are useful in inhibiting immune stimulation involving toll-like receptor 9 (TLR9). These can be used in treatment of autoimmune disease and inflammation where aberrant activation of TLR9 plays role.
本发明提供了新颖的式 1 嘌呤基化合物、嘌呤基化合物的制备方法及其组合物,可用于抑制通过 Toll 样受体发出的信号。这些化合物有助于抑制涉及Toll样受体9(TLR9)的免疫刺激。这些化合物可用于治疗 TLR9 异常激活的自身免疫性疾病和炎症。